JP2021531814A5 - - Google Patents
Info
- Publication number
- JP2021531814A5 JP2021531814A5 JP2021505349A JP2021505349A JP2021531814A5 JP 2021531814 A5 JP2021531814 A5 JP 2021531814A5 JP 2021505349 A JP2021505349 A JP 2021505349A JP 2021505349 A JP2021505349 A JP 2021505349A JP 2021531814 A5 JP2021531814 A5 JP 2021531814A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- polypeptide
- acid sequence
- seq
- polypeptide according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024095641A JP2024137947A (ja) | 2018-07-30 | 2024-06-13 | インターフェロン－ガンマバイアス型アゴニスト |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862712128P | 2018-07-30 | 2018-07-30 | |
| US62/712,128 | 2018-07-30 | ||
| PCT/US2019/043977 WO2020028275A1 (en) | 2018-07-30 | 2019-07-29 | Interferon-gamma biased agonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024095641A Division JP2024137947A (ja) | 2018-07-30 | 2024-06-13 | インターフェロン－ガンマバイアス型アゴニスト |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021531814A JP2021531814A (ja) | 2021-11-25 |
| JP2021531814A5 true JP2021531814A5 (enExample) | 2022-08-08 |
Family
ID=69230882
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505349A Ceased JP2021531814A (ja) | 2018-07-30 | 2019-07-29 | インターフェロン−ガンマバイアス型アゴニスト |
| JP2024095641A Pending JP2024137947A (ja) | 2018-07-30 | 2024-06-13 | インターフェロン－ガンマバイアス型アゴニスト |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024095641A Pending JP2024137947A (ja) | 2018-07-30 | 2024-06-13 | インターフェロン－ガンマバイアス型アゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12410226B2 (enExample) |
| EP (1) | EP3830115A4 (enExample) |
| JP (2) | JP2021531814A (enExample) |
| AU (1) | AU2019313339A1 (enExample) |
| CA (1) | CA3108066A1 (enExample) |
| MX (1) | MX2021001165A (enExample) |
| WO (1) | WO2020028275A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020028275A1 (en) | 2018-07-30 | 2020-02-06 | The Board Of Trustees Of The Leland Stanford Junior University | Interferon-gamma biased agonists |
| CN117242090A (zh) | 2021-03-30 | 2023-12-15 | 希望之城公司 | CAR T细胞疗法和IFNγ |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| JPS6124599A (ja) | 1984-07-11 | 1986-02-03 | Kyowa Hakko Kogyo Co Ltd | 新規ヒトインタ−フエロン−ｒポリペプチド誘導体 |
| US4845196A (en) | 1985-06-24 | 1989-07-04 | G. D. Searle & Co. | Modified interferon gammas |
| JP2969461B2 (ja) * | 1988-07-23 | 1999-11-02 | 株式会社林原生物化学研究所 | ヒトγ−インターフェロンとその製造方法並びに用途 |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| DE19535853C2 (de) | 1995-09-18 | 1999-04-01 | Fraunhofer Ges Forschung | Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung |
| CA2390292A1 (en) * | 1999-11-12 | 2001-05-25 | Maxygen Holdings Ltd. | Interferon gamma conjugates |
| US7038015B2 (en) * | 2001-04-06 | 2006-05-02 | Maxygen Holdings, Ltd. | Interferon gamma polypeptide variants |
| MXPA03011793A (es) | 2001-06-29 | 2004-04-02 | Maxygen Holdings Ltd | Formulaciones de interferon. |
| CA2491178A1 (en) * | 2002-07-03 | 2004-01-15 | Maxygen Holdings Ltd. | Full-length interferon gamma polypeptide variants |
| WO2006120580A2 (en) | 2005-05-04 | 2006-11-16 | Nautilus Biotech | Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides |
| WO2008076933A2 (en) | 2006-12-14 | 2008-06-26 | Bolder Biotechnology, Inc. | Long acting proteins and peptides and methods of making and using the same |
| US20080260820A1 (en) * | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
| CA2809747C (en) * | 2010-08-30 | 2018-05-01 | Roberto Testi | Compositions and methods for treating friedreich's ataxia with interferon gamma |
| WO2014106843A2 (en) * | 2013-01-01 | 2014-07-10 | Inuitive Ltd. | Method and system for light patterning and imaging |
| WO2018077893A1 (en) | 2016-10-24 | 2018-05-03 | Orionis Biosciences Nv | Targeted mutant interferon-gamma and uses thereof |
| WO2020028275A1 (en) | 2018-07-30 | 2020-02-06 | The Board Of Trustees Of The Leland Stanford Junior University | Interferon-gamma biased agonists |
| US20220000921A1 (en) * | 2018-11-20 | 2022-01-06 | Innovative Cellular Therapeutics Holdings, Ltd. | Modified Cell Expressing Therapeutic Agent and Uses thereof |
-
2019
- 2019-07-29 WO PCT/US2019/043977 patent/WO2020028275A1/en not_active Ceased
- 2019-07-29 MX MX2021001165A patent/MX2021001165A/es unknown
- 2019-07-29 AU AU2019313339A patent/AU2019313339A1/en not_active Abandoned
- 2019-07-29 EP EP19845344.1A patent/EP3830115A4/en not_active Withdrawn
- 2019-07-29 JP JP2021505349A patent/JP2021531814A/ja not_active Ceased
- 2019-07-29 CA CA3108066A patent/CA3108066A1/en active Pending
- 2019-07-29 US US17/264,140 patent/US12410226B2/en active Active
-
2024
- 2024-06-13 JP JP2024095641A patent/JP2024137947A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2557053B2 (ja) | 腫瘍壊死因子の精製、製造および使用法 | |
| RU2711979C2 (ru) | Белковый комплекс интерлейкина 15 и его применение | |
| Takeshita et al. | Cloning of the γ chain of the human IL-2 receptor | |
| CN105705641B (zh) | 涉及具有强烈降低的受体结合亲和力的细胞因子的融合因子 | |
| EP0713495B1 (en) | Methods of enhancing bioactivity of chemokines | |
| TWI250988B (en) | Thrombopoietic compounds | |
| JP2017529059A5 (enExample) | ||
| ES2289825T3 (es) | Nuevo procedimiento para la identificacion de un compuesto que modula la interaccion entre un ligando de tnf y su receptor en celulas b. | |
| CA3102821A1 (en) | Novel interleukin-15 (1l-15) fusion proteins and uses thereof | |
| CN101588820A (zh) | α-乳清蛋白组合物 | |
| CN108948207B (zh) | 一种人白细胞介素10-Fc融合蛋白及其编码基因与应用 | |
| WO2008000516B1 (en) | IMPROVED sgp130Fc DIMERS | |
| WO2003093478A1 (en) | Immunoconjugates for the treatment of tumours | |
| Madhankumar et al. | Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Rα2 | |
| JP2021535727A5 (enExample) | ||
| JP2021531814A5 (enExample) | ||
| JP2023510870A5 (enExample) | ||
| JP7830450B2 (ja) | 修飾されたｉｌ－２分子及びその用途 | |
| JPH03500415A (ja) | インターロイキン２類似体 | |
| ES2290156T3 (es) | Vector de expresion y secrecion del alfa interferon humano y procedimiento para producir alfa interferon humano empleando el anterior. | |
| WO2008152508A2 (en) | Cytokine conjugate | |
| AU2005298245A1 (en) | A thymus-specific protein | |
| TWI905155B (zh) | 包含 il-2蛋白及cd80蛋白片段或其變異體的融合蛋白及其用途 | |
| BR9707142A (pt) | Polinucleotìdeo purificado, dna, vetor, célula hospedeira, linhagem celular de hibridoma, anticorpo monoclonal, processos para produzir exodus, para aumentar a resistência à infecção por vìrus de imonudeficiência humana (hiv), para tratamento de infecção por vìrus de imonodeficiência humana (hiv), para proteção de células progenitoras de medula óssea contra os efeitos citotóxicos e para tratamento de doenças mieloproliferativas, e, uso de produto de proteina de exodus. | |
| JPH04505019A (ja) | ガンマインターフェロンのポリペプチド性阻害剤 |